Wedbush Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $173

Wedbush analyst Yun Zhong maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $118 to $173.